Here John Pracyk, MD, PhD, MBA, MAPS President of the Americas Region speaks with some of the top Medical Affairs leaders from Johnson & Johnson as they share their perspective on the impact of Digital on Healthcare.
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the future of the Medical Affairs function and the factors driving the current pace of change.
In a field where all professionals are esteemed intellectuals, the difference between a middling unknown and a Jeff Bezos is purely emotional intelligence.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
MAPS speaks with Medical Strategy FAWG co-leads Becky Harmon and Simon Kyaga about the emerging strategic opportunities for Medical Affairs.
At some point, many people feel they’re simply “not good enough.” Unfortunately, this is such a common occurrence that it has a name: Imposter Syndrome.
MedTech FAWG leaders discuss aspects of Medical Affairs unique to MedTech and how COVID and the changing data landscape have opened the door to the C-suite.
“Data doesn’t exist until it is published.” Here, MAPS speaks with MedComm FAWG co-leads about innovations and future directions for Medical Communications within Medical Affairs.
A Q&A with David Williams, Chief Medical Officer, VISFO
Since its publication in the journal of Therapeutic Innovation & Regulatory Science in July, the article “Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS,” has been read more than 4000 times. This article presents highlights from a recent MAPS webinar with the paper’s authors, focusing on further defining the role and best practices for Medical Science Liaisons.